Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Raz Mutai"'
Autor:
Itamar Averbuch, Roi Tschernichovsky, Oded Icht, Daniel A. Goldstein, Raz Mutai, Elizabeth Dudnik, Ofer Rotem, Nir Peled, Aaron M. Allen, Smadar Laufer‐Geva, Yael Goldberg, Alona Zer
Publikováno v:
Thoracic Cancer, Vol 14, Iss 17, Pp 1589-1596 (2023)
Abstract Background Mutations in genes involved in DNA damage repair (DDR), a hallmark of cancer, are associated with increased cancer cell sensitivity to certain therapies. This study sought to evaluate the association of DDR pathogenic variants wit
Externí odkaz:
https://doaj.org/article/b459005a45264617bf9d0dca54eb2f87
Autor:
Raz Mutai, Tamar Barkan, Assaf Moore, Michal Sarfaty, Tzippy Shochat, Rinat Yerushalmi, Salomon M. Stemmer, Hadar Goldvaser
Publikováno v:
Breast, Vol 60, Iss , Pp 62-69 (2021)
Background: Recent data suggest that human epidermal growth factor receptor 2 (HER2)-low breast cancer may represent a distinct entity. We aimed to compare disease characteristics and outcomes between HER2-low and HER2-0 in estrogen receptor (ER) pos
Externí odkaz:
https://doaj.org/article/c7b76536ee9b482e9a235ad0bc4badd8
Publikováno v:
Breast, Vol 58, Iss , Pp 173-181 (2021)
Background: Locoregional therapy (LRT) in de novo metastatic disease is controversial with inconsistent results from randomized control trials (RCTs). Methods: RCTs comparing LRT and systemic therapy to standard therapy alone in de novo metastatic br
Externí odkaz:
https://doaj.org/article/9c26485392c64b0f93b1be4bfbf1385a
Autor:
Yasmin Korzets, Orly Yariv, Raz Mutai, Assaf Moore, Tzippy Shochat, Rinat Yerushalmi, Hadar Goldvaser
Publikováno v:
Discover Oncology, Vol 12, Iss 1, Pp 1-13 (2021)
Abstract Background Menstrual and parity history might impact the risk for breast cancer. Data on the impact of these factors on other tumor characteristics are limited. Methods A single center retrospective cohort study comprising all women with est
Externí odkaz:
https://doaj.org/article/0dafa8a6c06c4a89a439ddfc3d07fd69
Autor:
Roi Tschernichovsky, Itamar Averbuch, Daniel Alex Goldstein, Raz Mutai, Elizabeth Dudnik, Ofer Rotem, Smadar Laufer-Geva, Nir Peled, Yael Goldberg, Alona Zer
Publikováno v:
Translational Lung Cancer Research. 12:1011-1022
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0a50379fe1e3b6d6d56003883930f61
https://doi.org/10.21037/tlcr-22-594
https://doi.org/10.21037/tlcr-22-594
Autor:
Itamar Averbuch, Roi Tschernichovsky, Oded Icht, Daniel A. Goldstein, Raz Mutai, Elizabeth Dudnik, Ofer Rotem, Nir Peled, Aaron M. Allen, Smadar Laufer‐Geva, Yael Goldberg, Alona Zer
Publikováno v:
Thoracic Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcc05382442851fc0a0efa053eb47209
https://doi.org/10.1111/1759-7714.14902
https://doi.org/10.1111/1759-7714.14902
Autor:
Assaf Moore, Michal Sarfaty, Tzippy Shochat, Raz Mutai, Tamar Barkan, Rinat Yerushalmi, Salomon M. Stemmer, Hadar Goldvaser
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 60, Iss, Pp 62-69 (2021)
Breast, Vol 60, Iss, Pp 62-69 (2021)
Background Recent data suggest that human epidermal growth factor receptor 2 (HER2)-low breast cancer may represent a distinct entity. We aimed to compare disease characteristics and outcomes between HER2-low and HER2-0 in estrogen receptor (ER) posi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c16880b10d4efe25cd0c2094cede2bad
https://doi.org/10.1016/j.breast.2021.08.016
https://doi.org/10.1016/j.breast.2021.08.016
Publikováno v:
Cancer Research. 81:PS1-50
Background: De novo metastatic breast cancer represents around 6% of breast cancer diagnoses. Retrospective data suggest that locoregional therapy (LRT) for the primary breast cancer in metastatic disease may improve outcomes. Randomized control tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a176d7877b39e9ec1b0ee5588956089
https://doi.org/10.1158/1538-7445.sabcs20-ps1-50
https://doi.org/10.1158/1538-7445.sabcs20-ps1-50
Autor:
Assaf Moore, Rinat Yerushalmi, Raz Mutai, Daliah Tsoref, Tzippy Shochat, Ofer Rotem, Hadar Goldvaser, Yasmin Korzets, Orly Yariv
Publikováno v:
Oncology. 99:713-721
Introduction: The impact of exogenous estrogen exposure on breast cancer characteristics and outcomes is not well described. We aimed to investigate the effect of prior treatment with oral contraceptives (OCT), hormone replacement therapy (HRT), and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4024f8f1cb14189702db9aa59b34ce1
https://doi.org/10.1159/000518183
https://doi.org/10.1159/000518183
Autor:
Orly Yariv, Rinat Yerushalmi, Assaf Moore, Hadar Goldvaser, Yasmin Korzets, Tzippy Shochat, Raz Mutai
Background: Menstrual and parity history might impact the risk for breast cancer. Data on the impact of these factors on other tumor characteristics are limited. Methods: A single center retrospective cohort study comprising all women with estrogen r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::371fffdbcfe73de78e22774485d96227
https://doi.org/10.21203/rs.3.rs-618743/v1
https://doi.org/10.21203/rs.3.rs-618743/v1
